Mar 02, 2020 / 01:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Fourth Quarter Seres Therapeutics Earnings Conference Call. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Mr. Carlo Tanzi, Head of Investor Relation. Please go ahead, sir.
Carlo Tanzi - Seres Therapeutics, Inc. - VP of IR & Corporate Communications
Thank you, Olivia, and good morning, everyone. A press release with the company's fourth quarter 2019 financial results and the business update became available at 7:00 a.m. Eastern Time this morning and can be found on the Investors and Media section of the company's website.
I'd like to remind you that we'll be making forward-looking statements relating to the timing, enrollment and results of our clinical studies, regulatory approval, the promise and potential impact of any of our microbiome therapeutics, the sufficiency of our cash and cash equivalents to fund operations and the ability of
Q4 2019 Seres Therapeutics Inc Earnings Call Transcript
Mar 02, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers